The role of cyclin-dependent kinase inhibitor p27 in squamous cell carcinoma of the esophagus

Pathology Research and Practice

Volumn 197, Issue 3, 2001, Pages 157-164

  Shibata, H ^a   Matsubara, O ^a   Wakiyama, H ^a   Tanaka, S ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Carcinogenesis; Esophagus; P27 expression; Prognosis; Squamous cell carcinoma

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; POLYCLONAL ANTIBODY; PROTEIN P27;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INVASION; CARCINOMA IN SITU; CONTROLLED STUDY; EARLY CANCER; EPITHELIUM DYSPLASIA; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; TUMOR DIFFERENTIATION;

EID: 0035068891     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1078/0344-0338-00027     Document Type: Article

References (45)

1. Positive correlation between p27Kip1 expression and progression of human esophageal squamous cell carcinoma
2. Prognostic implications of expression of the cell cycle inhibitor protein p27Kip1
3. Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer
4. KIP1 in multistage colorectal carcinogenesis
5. Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma
6. WAF1, a potential mediator of p53 tumor suppression
7. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissue
8. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer
9. Mutational analysis of the human cyclin-dependent kinase inhibitor p27kip1 in primary breast carcinomas
10. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China
11. p15ink4B is a potential effector of TGF-β-induced cell cycle arrest
12. The p21 CDK-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
13. Genetic analysis of human esophageal tumors from two high incidence geographic areas: Frequent p53 base substitutions and absence of ras mutations
14. Novel INK4 proteins, p19 and p18, are specific inhibitors of cyclin D-dependent kinases CDK4 and CDK6
15. Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers
16. Braking the cell cycle
17. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer
18. Reduced levels of cell-cycle inhibitor p27Kip1 in epithelial dysplasia and carcinoma of the oral cavity
19. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/kip1 in human malignancies
20. Cloning of p57/Kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution
21. p27kip1: A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers
22. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas
23. Frequent somatic mutation of the MST1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase4 inhibitor) gene in esophageal squamous cell carcinoma
24. Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer
25. Human cyclin D1 oncogene and esophageal squamous cell carcinoma
26. Role of the ubiquitin-protease pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
27. Cloning of p27kip1, A cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals
28. p27kip1, a cyclin-dependent kinase inhibitor, links transforming growth factor β and contact inhibition to cell cycle arrest
29. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and combination, correlate with survival in young breast cancer patients
30. p27kip1 Chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors
31. A new regulator motif in cell cycle control causing specific inhibitor of cyclin D/CDK4
32. Inhibition of Ras-induced proliferation and cellular transformation by p16ink4
33. Mammalian G1 cyclins
34. Absence of WAF1 mutations in a variety of human malignancies
35. Etiology and epidemiology of carcinoma of the esophagus
36. p27/Kip1 mutation found in breast cancer
37. Introduction of p21 (WAF-1/CIP1) during differentiation
38. Frequent loss of heterozygosity in the region of the Kip1 locus in non-small cell lung cancer: Evidence for a new tumor suppressor gene on the short arm of chromosome 12
39. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas
40. p27, a novel inhibitor of G1 cyclin-CDK protein kinase activity, is related to p21
41. Accumulation of p53 protein in human esophageal precancerous lesions: A possible early biomarker for carcinogenesis
42. Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydrdoxyvitamin D3 in HL60 cells
43. Research on esophageal cancer in China: A review
44. Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas
45. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck